Relationship between serum lipid values and atherosclerotic burden in the proximal thoracic aorta

Shun Kohsaka1, Zhezhen Jin, Tatjana Rundek

  • 1Department of Medicine, Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Insights

High-density lipoprotein cholesterol and Apo B/A-I ratio strongly predict aortic atherosclerosis. Total and LDL cholesterol levels were not significant predictors, indicating specific lipid markers are key for assessing plaque risk.

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Atherosclerosis Research

Background:

  • Investigated associations between lipid parameters and proximal thoracic aortic atherosclerosis.
  • Utilized a population-based cohort for cross-sectional analysis.

Purpose of the Study:

  • To compare the strength of associations among various lipid parameters and the presence of atherosclerotic plaque.
  • Identify key lipid predictors for proximal aortic atherosclerosis.

Main Methods:

  • Cross-sectional analysis of 464 subjects from the Aortic Plaques and Risk of Ischemic Stroke (APRIS) study.
  • Assessed atherosclerotic plaque presence and thickness via transesophageal echocardiography.
  • Measured lipid parameters: total cholesterol, triglycerides, LDL, HDL, non-HDL, lipoprotein (a), Apo B, Apo A-I, and Apo B/A-I ratio.

Main Results:

  • Atherosclerotic plaque detected in 70.4% of subjects; 37.6% had plaque >= 4 mm.
  • High-density lipoprotein cholesterol (HDL-C) and Apo B/A-I ratio were strongest predictors of any plaque.
  • HDL-C and Apo A-I levels predicted plaque >= 4 mm; Total and LDL cholesterol were not significant predictors.

Conclusions:

  • HDL-C levels and Apo B/A-I ratio are strongly associated with proximal aortic atherosclerosis.
  • Total and LDL cholesterol levels are not significantly associated with aortic atherosclerosis.
  • Specific lipid profiles, particularly HDL-C and Apo B/A-I, are crucial for assessing atherosclerosis risk.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...